COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
31 Dec 2020
Historique:
received: 22 06 2020
accepted: 02 10 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 18 11 2020
Statut: epublish

Résumé

The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in males, older individuals and patients with comorbidities. COPD patients are included in shielding strategies due to their susceptibility to virus-induced exacerbations, compromised pulmonary function and high prevalence of associated comorbidities. Using evidence from basic science and cohort studies, this review addresses key questions concerning COVID-19 and COPD. First, are there mechanisms by which COPD patients are more susceptible to SARS-CoV-2 infection? Secondly, do inhaled corticosteroids offer protection against COVID-19? And, thirdly, what is the evidence regarding clinical outcomes from COVID-19 in COPD patients? This up-to-date review tackles some of the key issues which have significant impact on the long-term outlook for COPD patients in the context of COVID-19.

Identifiants

pubmed: 33153991
pii: 29/158/200199
doi: 10.1183/16000617.0199-2020
pmc: PMC7651840
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: A. Higham reports personal fees from Chiesi, outside the submitted work. Conflict of interest: A. Mathioudakis reports grants from Boehringer Ingelheim outside the submitted work. Conflict of interest: J. Vestbo reports personal fees from AstraZeneca, Boehringer-Ingelheim, Chiesi, GSK and Novartis, and grants from Boehringer-Ingelheim, outside the submitted work. Conflict of interest: D. Singh reports personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Gossamerbio, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Theravance and Verona, outside the submitted work.

Références

Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300
pubmed: 32228035
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Am J Respir Crit Care Med. 2016 Sep 1;194(5):541-9
pubmed: 27585383
Int J Chron Obstruct Pulmon Dis. 2012;7:653-61
pubmed: 23055714
Am J Respir Crit Care Med. 2020 Jul 15;202(2):219-229
pubmed: 32432483
Thorax. 2012 Dec;67(12):1075-80
pubmed: 22863758
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32366720
J Virol. 2014 Jan;88(2):1293-307
pubmed: 24227843
Eur Respir J. 2020 Jul 16;56(1):
pubmed: 32444400
Eur Respir J. 2017 Mar 6;49(3):
pubmed: 28182564
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90
pubmed: 32348692
Respir Investig. 2020 May;58(3):155-168
pubmed: 32094077
Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4251-E4260
pubmed: 28484023
J Allergy Clin Immunol. 2020 Dec;146(6):1292-1294
pubmed: 31953103
Cytokine. 2009 Dec;48(3):246-53
pubmed: 19748795
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):737-44
pubmed: 11254533
Chest. 2006 Feb;129(2):317-324
pubmed: 16478847
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
Lancet Respir Med. 2019 Sep;7(9):745-756
pubmed: 31281061
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Endocrinology. 2004 Oct;145(10):4703-11
pubmed: 15231706
PLoS One. 2020 May 11;15(5):e0233147
pubmed: 32392262
Chest. 1994 May;105(5):1360-4
pubmed: 8181320
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
J Nutr Biochem. 2017 Oct;48:74-82
pubmed: 28779634
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BMJ Open. 2020 Nov 27;10(11):e040736
pubmed: 33247020
N Engl J Med. 2018 May 03;378(18):1671-1680
pubmed: 29668352
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32366483
Eur Respir J. 2020 May 27;55(5):
pubmed: 32108044
Eur Respir J. 2018 Dec 13;52(6):
pubmed: 30190269
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
Lancet Respir Med. 2018 May;6(5):337-344
pubmed: 29605624
Ann Intern Med. 2009 Oct 20;151(8):517-27
pubmed: 19841453
J Surg Res. 2002 May 15;104(2):77-81
pubmed: 12020123
J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5
pubmed: 33068560
Metabolism. 2002 Jun;51(6 Suppl 1):25-30
pubmed: 12040537
J Clin Med. 2020 Mar 20;9(3):
pubmed: 32244852
J Virol. 2005 Dec;79(23):14614-21
pubmed: 16282461
Eur Respir J. 2019 May 18;53(5):
pubmed: 30846476
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
Am J Respir Crit Care Med. 2020 May 1;201(9):1078-1085
pubmed: 31922913
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24
pubmed: 23024024
Thromb Res. 2009 Jul;124(3):259-61
pubmed: 19162305
Am J Respir Cell Mol Biol. 2016 Jul;55(1):117-27
pubmed: 26807508
Clin Exp Allergy. 2009 Nov;39(11):1700-10
pubmed: 19549024
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32350104
Allergy. 2020 Nov;75(11):2829-2845
pubmed: 32496587
Am J Respir Crit Care Med. 2014 Jul 1;190(1):40-50
pubmed: 24825462
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Sci Rep. 2014 Nov 24;4:7176
pubmed: 25417801
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559
pubmed: 32329629
Thorax. 2005 Nov;60(11):925-31
pubmed: 16055622
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71
pubmed: 21680942
PLoS One. 2013 Aug 19;8(8):e71629
pubmed: 23977094
Respir Res. 2016 Oct 28;17(1):140
pubmed: 27793198
Cardiovasc Pathol. 2020 Sep - Oct;48:107233
pubmed: 32434133
J Allergy Clin Immunol. 2012 Sep;130(3):770-780.e11
pubmed: 22578901
Hypertension. 1997 Jan;29(1 Pt 2):366-73
pubmed: 9039129
Obesity (Silver Spring). 2020 Sep;28(9):1586-1589
pubmed: 32428380
Thorax. 2020 Jun;75(6):520-527
pubmed: 32217784
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
Lancet Respir Med. 2020 May;8(5):436-438
pubmed: 32251625
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32341101
Lancet. 2017 May 13;389(10082):1919-1929
pubmed: 28385353
Int J Chron Obstruct Pulmon Dis. 2018 Apr 19;13:1279-1288
pubmed: 29719383
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
EMBO J. 2020 May 18;39(10):e105114
pubmed: 32246845
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Am J Respir Crit Care Med. 2018 Sep 15;198(6):739-750
pubmed: 29547002
Sci Rep. 2017 Oct 30;7(1):14369
pubmed: 29084974
Respir Res. 2019 Mar 4;20(1):49
pubmed: 30832670
Nat Rev Immunol. 2006 Jan;6(1):44-55
pubmed: 16493426
Eur Respir J. 2020 May 7;55(5):
pubmed: 32341100
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Lancet Respir Med. 2016 Nov;4(11):911-924
pubmed: 27264777
Clin Sci (Lond). 2020 Apr 17;134(7):751-763
pubmed: 32227160
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Eur Respir J. 2014 Jul;44(1):87-96
pubmed: 24627537
Chest. 2017 Mar;151(3):544-554
pubmed: 27522956
Eur Respir J. 2017 Oct 5;50(4):
pubmed: 28982774
PLoS One. 2020 Dec 17;15(12):e0243027
pubmed: 33332356
Respir Res. 2020 Jun 29;21(1):163
pubmed: 32600344
Clin Microbiol Infect. 2020 Nov;26(11):1545-1553
pubmed: 32781244
Nat Commun. 2018 Jun 8;9(1):2229
pubmed: 29884817
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Am J Respir Crit Care Med. 2015 Aug 15;192(4):523-5
pubmed: 26051430
Lancet Respir Med. 2018 Feb;6(2):117-126
pubmed: 29331313
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Eur Respir J. 2017 Jun 15;49(6):
pubmed: 28619964
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Lancet. 2018 Mar 17;391(10125):1076-1084
pubmed: 29429593
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1796-1800
pubmed: 32506122
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Eur J Hum Genet. 2020 Nov;28(11):1602-1614
pubmed: 32681121
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
J Virol. 2010 Jan;84(2):1198-205
pubmed: 19864379
Thorax. 2005 Oct;60(10):882
pubmed: 16055610

Auteurs

Andrew Higham (A)

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK Andrew.Higham@manchester.ac.uk.

Alexander Mathioudakis (A)

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.

Jørgen Vestbo (J)

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.

Dave Singh (D)

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
Medicines Evaluation Unit, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH